Metabolomic profiling of cardiac allografts after controlled circulatory death - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The Journal of Heart and Lung Transplantation Année : 2023

Metabolomic profiling of cardiac allografts after controlled circulatory death

Thaïs Hautbergue
Florent Laverdure
Simon Dang Van
  • Fonction : Auteur
Benoît Decante
Maïra Gaillard
Olaf Mercier

Résumé

BACKGROUND: Assessment of myocardial viability during ex situ heart perfusion (ESHP) is based on the measurement of lactate concentrations. As this provides with limited information, we sought to investigate the metabolic signature associated with donation after circulatory death (DCD) and the impact of ESHP on the myocardial metabolome.METHODS: Porcine hearts were retrieved either after warm ischemia (DCD group, N = 6); after brain-stem death (BSD group, N = 6); or without DCD nor BSD (Control group, N = 6). Hearts were perfused using normothermic oxygenated blood for 240 minutes. Plasma and myocardial samples were collected respectively every 30 and 60 minutes, and analyzed by an untargeted metabolomic approach using liquid chromatography coupled to high-resolution mass spectrometry.RESULTS: Median duration of warm ischemia was 23 minutes [19-29] in DCD animals. Lactate level within myocardial biopsies was not significantly different between groups at T0 (p = 0.281), and remained stable over the 4-hour period of ESHP. More than 300 metabolites were detected in plasma and heart biopsy samples. Compared to BSD animals, metabolomics changes involving energy and nucleotide metabolisms were observed in plasma samples of DCD animals before initiation of ESHP, whereas 2 metabolites (inosine monophosphate and methylbu-tyrate) exhibited concentration changes in biopsy samples. Normalization of DCD metabolic pro-file was remarkable after 4 hours of ESHP. CONCLUSION: A specific metabolic profile was observed in DCD hearts, mainly characterized by an increased nucleotide catabolism. DCD and BSD metabolomes proved normalized during ESHP. Complementary investigations are needed to correlate these findings to cardiac performances.
Fichier non déposé

Dates et versions

hal-04455530 , version 1 (13-02-2024)

Identifiants

Citer

Thaïs Hautbergue, Florent Laverdure, Simon Dang Van, Aurelien Vallee, Mateo Sanchis-Borja, et al.. Metabolomic profiling of cardiac allografts after controlled circulatory death. The Journal of Heart and Lung Transplantation, 2023, 42 (7), pp.870-879. ⟨10.1016/j.healun.2023.02.1492⟩. ⟨hal-04455530⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More